MetLife, Inc. (NYSE:MET) Shares Sold by Desjardins Global Asset Management Inc.

Desjardins Global Asset Management Inc. lessened its stake in MetLife, Inc. (NYSE:MET - Free Report) by 73.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,663 shares of the financial services provider's stock after selling 18,398 shares during the period. Desjardins Global Asset Management Inc.'s holdings in MetLife were worth $441,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. FWL Investment Management LLC purchased a new position in shares of MetLife during the 4th quarter worth $26,000. Quintet Private Bank Europe S.A. bought a new position in MetLife in the 3rd quarter worth $28,000. Planned Solutions Inc. bought a new position in MetLife in the 4th quarter worth $28,000. Eagle Bay Advisors LLC bought a new position in MetLife in the 2nd quarter worth $28,000. Finally, Studio Investment Management LLC bought a new position in MetLife in the 4th quarter worth $29,000. Institutional investors own 89.81% of the company's stock.

Insider Transactions at MetLife

In other news, insider Ramy Tadros sold 4,026 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the transaction, the insider now directly owns 146,981 shares in the company, valued at $10,567,933.90. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the completion of the sale, the executive vice president now directly owns 57,768 shares in the company, valued at $4,174,893.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now owns 146,981 shares of the company's stock, valued at $10,567,933.90. The disclosure for this sale can be found here. Corporate insiders own 0.32% of the company's stock.

MetLife Trading Up 1.5 %

Shares of NYSE:MET traded up $1.03 during trading on Thursday, reaching $69.95. 2,649,826 shares of the company were exchanged, compared to its average volume of 3,563,567. The firm has a market capitalization of $50.58 billion, a PE ratio of 38.13, a P/E/G ratio of 0.52 and a beta of 1.04. The business's fifty day simple moving average is $70.98 and its 200-day simple moving average is $66.68. MetLife, Inc. has a 12-month low of $48.95 and a 12-month high of $74.68. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:MET - Get Free Report) last issued its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 EPS for the quarter, missing analysts' consensus estimates of $1.95 by ($0.02). The company had revenue of $18.72 billion for the quarter, compared to analysts' expectations of $18.07 billion. MetLife had a return on equity of 19.48% and a net margin of 2.36%. On average, research analysts anticipate that MetLife, Inc. will post 8.71 EPS for the current year.

Analyst Ratings Changes

Several research firms have commented on MET. Keefe, Bruyette & Woods increased their price objective on shares of MetLife from $82.00 to $87.00 and gave the company an "outperform" rating in a report on Wednesday, April 10th. Piper Sandler upped their target price on shares of MetLife from $74.00 to $85.00 and gave the company an "overweight" rating in a research report on Friday, April 5th. The Goldman Sachs Group upgraded shares of MetLife from a "neutral" rating to a "buy" rating and upped their target price for the company from $70.00 to $80.00 in a research report on Monday, January 8th. Wells Fargo & Company upped their target price on shares of MetLife from $83.00 to $86.00 and gave the company an "overweight" rating in a research report on Thursday, April 11th. Finally, Morgan Stanley upped their target price on shares of MetLife from $80.00 to $82.00 and gave the company an "overweight" rating in a research report on Monday. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $79.23.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.